The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Sertraline for social phobia: a double-blind, placebo-controlled crossover study
Abstract
OBJECTIVE: The authors examined the efficacy of sertraline in the treatment of social phobia. METHOD: In a double-blind crossover study, 12 outpatients were randomly assigned to 10 weeks of sertraline (50-200 mg/day, flexible dosing) and 10 weeks of placebo. RESULTS: A statistically significant improvement in scores on the Liebowitz Social Anxiety Scale was found with sertraline but not with placebo. There was no significant difference between scores obtained with computer- and clinician-administered versions of the Liebowitz Social Anxiety Scale, and the majority of patients preferred to be interviewed by the computer. CONCLUSIONS: Sertraline seems a safe and effective treatment for social phobia, and computer administration may be a preferable mode of assessment with socially phobic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLES
COCHRAN, W. G. (1950) · Biometrika · doi:10.1093/biomet/37.3-4.256 · Cited by 1,465
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.12.1521 · Cited by 301
Research works printed but not linked: 31
- 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
- 10.1016/0165-0327(87)90022-X · DOI
- Liebowitz MR, Gulley R
- Lydiard RB, 1988, J Clin Psychiatry, 49, 17
- 10.1176/ajp.145.5.590 · DOI
- 10.1097/00004714-199312000-00008 · DOI · Paper page
- 10.1097/00004714-199006000-00024 · DOI
- McGlynn TJ, Metcalf HL: Diagnosis and Treatment of Anxiety Disorders: A Physician's Handbook. Washington, can Psychiatric Press, 1989, pp93-96
- 10.1001/archpsyc.1985.01790300097013 · DOI · Paper page
- 1993, Br J Psychiatry, 163, 40, 10.1192/S0007125000292362 · doi:10.1192/s0007125000292362
- Wernicke JF, Dornseif BE
- Dunner DL, 1992, J Clin Psychiatry, 53, 21
- 10.1097/00004714-199202000-00018 · DOI
- 10.1097/00004714-199208000-00022 · DOI
- Van Ameringen M, 1993, J Clin Psychiatry, 54, 27
- Van Ameringen M, 1994, Neuropsychopharmacology, 10, 1965
- Czepowicz VD, 1994, 147th Annual Meeting of the American Psychiatnc Association
- 10.1007/BF02244762 · DOI · Paper page
- Davidson JRT, 1991, Wilson W: The Brief Social Phobia Scale.J Clin Psychiatry, 52, 48
- Stewart AL, 1988, Med Cane, 26, 724
- Liebowitz MR, 1988, J Clin Psychiatry, 49, 242
- 10.1111/j.1365-2125.1979.tb05903.x · DOI · Paper page
- 10.1207/s15327752jpa6301_14 · DOI
- 10.1038/clpt.1993.64 · DOI
- 10.1177/106002809202600303 · DOI
- 10.1097/00004714-199106000-00024 · DOI
- 10.1192/bjp.161.3.353 · DOI · Paper page
- 10.1001/archpsyc.1995.03950160039008 · DOI · Paper page
- 10.1037/1040-3590.4.3.329 · DOI · Paper page
- 10.1037/1040-3590.2.1.56 · DOI
- 10.1037/1040-3590.5.4.487 · DOI
Cited by
Stein, M. B., & Stein, D. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60488-2 · Cited by 1,137
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., Juster, H. R., Campeas, R., Bruch, M. A., Cloitre, M., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1133 · Cited by 585
Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis.
Gould, R. A., Buckminster, S., Pollack, M. H., Otto, M. W., & Yap, L. (1997) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.1997.tb00123.x · Cited by 438
Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415
Psychological and Pharmacological Treatments of Social Phobia: A Meta-Analysis
Fedoroff, I. C., & Taylor, S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00011 · Cited by 396
Treatment of Social Phobia With Gabapentin: A Placebo-Controlled Study
Pande, A. C., Davidson, J. R. T., Jefferson, J. W., Janney, C. A., Katzelnick, D. J., Weisler, R. H., Greist, J. H., & Sutherland, S. M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00010 · Cited by 395
Barriers to the Treatment of Social Anxiety
Olfson, M., Guardino, M., Struening, E., Schneier, F. R., Hellman, F., & Klein, D. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.521 · Cited by 356
Stein, M. B., Liebowitz, M. R., Lydiard, R. B., Pitts, C. D., Bushnell, W., & Gergel, I. (1998) · JAMA · doi:10.1001/jama.280.8.708 · Cited by 348
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Review of sertraline and its clinical applications in psychiatric disorders
McRae, A. L., & Brady, K. T. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.5.883 · Cited by 287
Stein, M. B., Fyer, A. J., Davidson, J. R. T., Pollack, M. H., & Wiita, B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.756 · Cited by 262
Romero, L. M., & Remage-Healey, L. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7491 · Cited by 259
Social Anxiety Disorder: (532272011-001)
(2008) · PsycEXTRA Dataset · doi:10.1037/e532272011-001 · Cited by 258
A Computer-Administered Telephone Interview to Identify Mental Disorders
Kobak, K. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550110043034 · Cited by 238
Self-citationPande, A. C., Feltner, D. E., Jefferson, J. W., Davidson, J. R. T., Pollack, M., Stein, M. B., Lydiard, R. B., Futterer, R., Robinson, P., Slomkowski, M., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000117423.05703.e7 · Cited by 227
Self-citationSocial anxiety disorder in childhood and adolescence: Current status and future directions
Kashdan, T. B., & Herbert, J. D. (2001) · Clinical Child and Family Psychology Review · doi:10.1023/a:1009576610507 · Cited by 205
Browne, G., Steiner, M., Roberts, J., Gafni, A., Byrne, C., Dunn, E., Bell, B., Mills, M., Chalklin, L., Wallik, D., et al. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00343-3 · Cited by 199
Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety
Kent, J. M., Coplan, J. D., & Gorman, J. M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00210-8 · Cited by 196
Otto, M. W., Pollack, M. H., Gould, R. A., Worthington, J. J., McArdle, E. T., Rosenbaum, J. F., & Heimberg, R. G. (2000) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(00)00027-x · Cited by 175
Lader, M., Stender, K., Bürger, V., & Nil, R. (2004) · Depression and Anxiety · doi:10.1002/da.20014 · Cited by 163
“, 1994], sertraline [Katzelnick et al., 1995], gabapentin [Pande et al.”
BackgroundSocial phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment
Brunello, N., den Boer, J. A., Judd, L. L., Kasper, S., Kelsey, J. E., Lader, M., Lecrubier, Y., Lepine, J. P., Lydiard, R. B., Mendlewicz, J., et al. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00140-8 · Cited by 153
“…citalopram (Lepola et al., 1994 and Bouwer and Stein, 1998), open trials for fluoxetine (Schneier et al., 1992b; Van Ameringen et al., 1993) and double blind placebo controlled studies for fluvoxamine (Van Vliet et al., 1994), paroxetine (Stein et al., 1996a), sertraline (Katzelnick et al., 1995).”
BackgroundExposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial
Haug, T. T., Blomhoff, S., Hellstrøm, K., Holme, I., Humble, M., Madsbu, H. P., & Wold, J. E. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.4.312 · Cited by 151
Montgomery, S. A., Nil, R., Dürr-Pal, N., Loft, H., & Boulenger, J.-P. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1009 · Cited by 115
The evidence-based pharmacotherapy of social anxiety disorder
Blanco, C., Bragdon, L. B., Schneier, F. R., & Liebowitz, M. R. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000119 · Cited by 99
Social Phobia: Epidemiology and Cost of Illness
Lipsitz, J. D., & Schneier, F. R. (2000) · PharmacoEconomics · doi:10.2165/00019053-200018010-00003 · Cited by 92
Pharmacotherapy of social anxiety disorder
Blanco, C., Antia, S. X., & Liebowitz, M. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01294-x · Cited by 88
Pharmacotherapy for social anxiety disorder (SAnD)
Williams, T., Hattingh, C. J., Kariuki, C. M., Tromp, S. A., van Balkom, A. J., Ipser, J. C., & Stein, D. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001206.pub3 · Cited by 84
Walker, J. R., Van Ameringen, M. A., Swinson, R., Bowen, R. C., Chokka, P. R., Goldner, E., Johnston, D. C., Lavallie, Y.-J., Nandy, S., Pecknold, J. C., et al. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00009 · Cited by 84
Anxiety and Depression: Optimizing Treatments
Ballenger, J. C. (2000) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v02n0301 · Cited by 83
Evidence-based pharmacotherapy for personality disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000071 · Cited by 83
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment
Atmaca, M., Tezcan, E., Kuloglu, M., Ustundag, B., & Tunckol, H. (2004) · European Archives of Psychiatry and Clinical Neurosciences · doi:10.1007/s00406-004-0484-3 · Cited by 75
Pharmacotherapy of social phobia
Davidson, J. R. T. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s417.7.x · Cited by 69
Social anxiety disorder/social phobia: Epidemiology, diagnosis, neurobiology, and treatment
den Boer, J. A. (2000) · Comprehensive Psychiatry · doi:10.1053/comp.2000.16564 · Cited by 67
Curtiss, J., Andrews, L., Davis, M., Smits, J., & Hofmann, S. G. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1285907 · Cited by 46
Computer aids to mental health care
Marks, I. (1999) · The Canadian Journal of Psychiatry · doi:10.1177/070674379904400602 · Cited by 43
Nagata, T., Suzuki, F., & Teo, A. R. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12327 · Cited by 40
Stein, D., Stein, M., Goodwin, W., Kumar, R., & Hunter, B. (2001) · Psychopharmacology · doi:10.1007/s002130100880 · Cited by 39
MONTGOMERY, S. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.06.001 · Cited by 18
Psychopharmacology for Social Anxiety Disorder
Blanco, C., Bragdon, L., Schneier, F. R., & Liebowitz, M. R. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00022-4 · Cited by 2
Efficacy of Paroxetine for Relapse Prevention in Social Anxiety Disorder: A 24-Week Study
Stein, D. J., Versiani, M., Hair, T., & Kumar, R. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1111
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1995-09-01
- Volume
- 152
- Issue
- 9
- Pages
- 1368-1371
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W79306445
- Cited by
- 238
- References
- 5
- FWCI
- 21.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.